Physician Assistant, Medical · Dakota Dunes, SD
NPI
1225332463
Since 2011
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
705 N Sioux Point Rd, Suite 100
Dakota Dunes, SD, 57049
Phone (605) 217-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
4,314 services
Medicare patients, 2024
278
Average age 72
Drug cost, 2024
$3.3M
6,374 prescriptions
Company payments, 2025
$30K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Molly E Schooley was code 99214 (office e&m - established), 862 times for 249 patients. In total Molly E Schooley billed 4,314 services in 41 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 862 | 249 | $65.41 | $56K |
| 36415 Venipuncture Blood Collection | Office | 651 | 245 | $8.65 | $5,631 |
| 83036 Blood Count | Office | 568 | 211 | $9.52 | $5,407 |
| 95251 Test - Miscellaneous | Office | 393 | 118 | $20.55 | $8,077 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 295 | 204 | $10.27 | $3,028 |
| 80053 Clinical Chemistry | Office | 183 | 135 | $10.35 | $1,894 |
| 82570 Clinical Chemistry | Office | 98 | 93 | $5.08 | $498 |
| 82044 Clinical Chemistry | Office | 98 | 93 | $6.11 | $599 |
| 84443 Clinical Chemistry | Office | 65 | 40 | $16.46 | $1,070 |
| 99213 Office E&M - Established | Office | 58 | 40 | $40.88 | $2,371 |
| 84439 Clinical Chemistry | Office | 58 | 33 | $8.84 | $513 |
| 80048 Clinical Chemistry | Office | 39 | 32 | $8.29 | $323 |
| 85025 Blood Count | Office | 28 | 24 | $7.61 | $213 |
| 82306 Clinical Chemistry | Office | 15 | 14 | $29.01 | $435 |
By year: 2022 $85K for 3,318 services; 2023 $96K for 3,741 services; 2024 $105K for 4,314 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 651 | 245 | $8.65 | $5,631 |
| 83036 Blood Count | 568 | 211 | $9.52 | $5,407 |
| 80053 Clinical Chemistry | 183 | 135 | $10.35 | $1,894 |
| 82570 Clinical Chemistry | 98 | 93 | $5.08 | $498 |
| 82044 Clinical Chemistry | 98 | 93 | $6.11 | $599 |
| 84443 Clinical Chemistry | 65 | 40 | $16.46 | $1,070 |
| 84439 Clinical Chemistry | 58 | 33 | $8.84 | $513 |
| 80048 Clinical Chemistry | 39 | 32 | $8.29 | $323 |
| 85025 Blood Count | 28 | 24 | $7.61 | $213 |
| 82306 Clinical Chemistry | 15 | 14 | $29.01 | $435 |
Medicare prescription drug claims, 2024
In 2024, the drug Molly E Schooley prescribed most often to Medicare patients was Ozempic (Semaglutide), with 475 prescriptions and refills. In total Molly E Schooley wrote 6,374 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 475 | 574 | 72 | $539K |
| Farxiga Dapagliflozin Propanediol | 387 | 514 | 64 | $272K |
| Jardiance Empagliflozin | 380 | 518 | 63 | $287K |
| Tresiba Flextouch U-100 Insulin Degludec | 321 | 573 | 81 | $140K |
| Metformin Hcl Generic | 316 | 575 | 65 | $1,135 |
| Mounjaro Tirzepatide | 269 | 288 | 44 | $294K |
| Tresiba Flextouch U-200 Insulin Degludec | 260 | 372 | 46 | $272K |
| Novolog Flexpen Insulin Aspart | 219 | 320 | 68 | $51K |
| Trulicity Dulaglutide | 207 | 235 | 33 | $228K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 201 | 251 | 37 | $277K |
| Levothyroxine Sodium Generic | 196 | 459 | 49 | $1,896 |
| Glipizide Er Glipizide | 194 | 362 | 43 | $1,703 |
| Metformin Hcl Er Metformin Hcl | 167 | 318 | 41 | $976 |
| Glipizide Generic | 148 | 290 | 33 | $985 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 135 | 191 | 29 | $103K |
Brand drugs: 4,142 claims; generic drugs: 1,770 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Molly E Schooley $30K ($30K in general payments such as food, travel and fees) from 30 companies. The largest payer was Novo Nordisk Inc with $23K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 37 | $23K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 24 | $5,269 |
| Novo Nordisk AS NVO | 1 | $330 |
| Pfizer Inc. PFE | 11 | $165 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $163 |
| Abbvie Inc. ABBV | 10 | $153 |
| Insulet Corporation PODD | 1 | $150 |
| Xeris Pharmaceuticals, Inc. | 5 | $80.61 |
| Mannkind Corporation MNKD | 2 | $62.99 |
| Astellas Pharma US Inc 4503.T | 4 | $62.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.